相关实验视频
Updated: Jul 15, 2025

11:02
Isolation and Physiological Analysis of Mouse Cardiomyocytes
Published on: September 7, 2014
23.2K
甲状腺激素诱导限制性心肌病在β1-adrenoceptor淘汰赛小鼠
Anderson L B da Silveira1,2,3, Fernando A C Seara2,3, Danilo Lustrino4
1Departamento de Educação Física e Desportos, Instituto de Educação, Universidade Federal Rural do Rio de Janeiro, Seropédica, Rio de Janeiro, Brasil.
Canadian journal of physiology and pharmacology
|September 25, 2023
概括
在甲状腺激素诱导的心脏缩 (TiCH) 中,β1-上腺素受体 (β1-AR) 信号传递是必不可少的. 阻断β1-AR会损害心脏功能,并改变与TiCH有关的信号通路.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 甲状腺激素在心脏功能和发育中起着至关重要的作用.
- 甲状腺激素诱导的心脏缩 (TiCH) 涉及复杂的信号通路.
- β1-上腺素受体 (β1-AR) 是心脏功能的关键调节者.
研究的目的:
- 调查β1-AR信号传递在TiCH中的作用.
- 探索β1-AR,心脏氨酸-血管新生系统和甲状腺激素信号传递之间的交叉对话.
- 阐明β1-AR在TiCH中的参与背后的分子机制.
主要方法:
- 给野生型 (WT) 和β1-AR淘汰 (β1-KO) 老鼠注射三甲状腺素 (T3).
- 心声图和心肌组织学用于心脏功能和结构评估.
- 测量心脏和血清 ангиотензин (ANGI/ANGII),心房 natriuretic (ANP) 和关键信号蛋白 (p-PKA,p-ERK1/2,p-p38-MAPK,p-AKT,p-4EBP1,ACE) 的作用.
主要成果:
- 用T3治疗的WT小鼠显示心脏尺寸发生变化 (IVSTd下降,LVEDD增加).
- 用T3治疗的β1-KO小鼠表现出心脏功能受损 (较低的喷射分数) 和心肌细胞大小增加.
- T3治疗增加了心脏ACE表达,而心脏ANP水平在WT T3与β1-KO T3相比下降. 特定的信号通路 (p38-MAPK,4EBP1,ERK1/2) 通过T3和β1-AR状态进行了差异调节.
结论:
- β1-AR信号传递对于正常的心脏适应甲状腺激素过量是不可或缺的.
- 破坏β1-AR信号加剧了心脏功能障碍,并改变了TiCH中的过度缩信号.
- 这些发现强调β1-AR作为甲状腺激素诱导的心脏重塑的关键调解者.
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
881
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
881
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Adrenergic Receptors: β Subtype
1.7K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.7K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
507
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
507

